NextPlat Corp Quarterly report pursuant to Section 13 or 15(d)

Note 20 - Reportable Segments (Tables)

6 Months Ended

Jun. 30, 2024

For the Three Months Ended June 30, 2024	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	-		$	10,521		$	-		$	10,521
e-Commerce revenue		3,512			-			-			3,512
Pharmacy 340B contract revenue		-			2,956			-			2,956
Revenues, net	$	3,512		$	13,477		$	-		$	16,989

Expenses:
Cost of revenue		2,401			8,782			-			11,183
Selling, general and administrative		1,382			895			(60	)		2,217
Salaries, wages and payroll taxes		619			2,166			-			2,785
Impairment loss		-			9,792			-			9,792
Professional fees		620			384			-			1,004
Depreciation and amortization		146			757			-			903
		5,168			22,776			(60	)		27,884
Loss before other (income) expense		(1,656	)		(9,299	)		60			(10,895	)
Other income		(210	)		(23	)		(60	)		(173	)
Loss before income taxes		(1,446	)		(9,276	)		-			(10,722	)
Income taxes		(20	)		-			-			(20	)
Net loss	$	(1,466	)	$	(9,276	)	$	-		$	(10,742	)

For the Three Months Ended June 30, 2023	*e-Commerce Operations*			*Healthcare Operations*		*Eliminations*		*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	-		$	-	$	-	$	-
e-Commerce revenue		2,957			-		-		2,957
Pharmacy 340B contract revenue		-			-		-		-
Revenues, net	$	2,957		$	-	$	-	$	2,957

Expenses:
Cost of revenue		2,113			-		-		2,113
Selling, general and administrative		2,519			-		-		2,519
Salaries, wages and payroll taxes		968			-		-		968
Professional fees		544			-		-		544
Depreciation and amortization		168			-		-		168
		6,312			-		-		6,312
Loss before other (income) expense		(3,355	)		-		-		(3,355	)
Other income		(473	)		-		-		(473	)
Loss before income taxes		(2,882	)		-		-		(2,882	)
Income taxes		(52	)		-		-		(52	)
Loss before equity method investment		(2,934	)		-		-		(2,934	)
Equity in net loss of affiliate		(1,407	)		-		-		(1,407	)
Net loss	$	(4,341	)	$	-	$	-	$	(4,341	)

For the Six Months Ended June 30, 2024	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	-		$	21,773		$	-		$	21,773
e-Commerce revenue		6,377			-			-			6,377
Pharmacy 340B contract revenue		-			6,332			-			6,332
Revenues, net	$	6,377		$	28,105		$	-		$	34,482

Expenses:
Cost of revenue		4,462			19,405			-			23,867
Selling, general and administrative		2,545			1,795			(120	)		4,220
Salaries, wages and payroll taxes		1,127			4,282			-			5,409
Impairment loss		-			9,924			-			9,924
Professional fees		1,127			862			-			1,989
Depreciation and amortization		277			1,533			-			1,810
		9,538			37,801			(120	)		47,219
Loss before other (income) expense		(3,161	)		(9,696	)		120			(12,737	)
Other income		(413	)		(48	)		(120	)		(341	)
Loss before income taxes		(2,748	)		(9,648	)		-			(12,396	)
Income taxes		(47	)		-			-			(47	)
Net (loss) income	$	(2,795	)	$	(9,648	)	$	-		$	(12,443	)

For the Six Months Ended June 30, 2023	*e-Commerce Operations*			*Healthcare Operations*		*Eliminations*		*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	-		$	-	$	-	$	-
e-Commerce revenue		5,834			-		-		5,834
Pharmacy 340B contract revenue		-			-		-		-
Revenues, net	$	5,834		$	-	$	-	$	5,834

Expenses:
Cost of revenue		4,369			-		-		4,369
Selling, general and administrative		3,308			-		-		3,308
Salaries, wages and payroll taxes		1,556			-		-		1,556
Professional fees		865			-		-		865
Depreciation and amortization		330			-		-		330
		10,428			-		-		10,428
Loss before other (income) expense		(4,594	)		-		-		(4,594	)
Other income		(558	)		-		-		(558	)
Loss before income taxes		(4,036	)		-		-		(4,036	)
Income taxes		(52	)		-		-		(52	)
Loss before equity method investment		(4,088	)		-		-		(4,088	)
Equity in net loss of affiliate		(1,440	)		-		-		(1,440	)
Net loss	$	(5,528	)	$	-	$	-	$	(5,528	)